SUNPHARMA shows sign of weakness as investors do cost averaging
18 Mar, 20245 min read
SUNPHARMA managed to outperform the broader market today. On a longer term basis, investors in SUN PHARMACEUTICAL IND L made -0.02% per day. Monday's performance of +1.49% was a outperformance compared to it's daily average.